Netakimab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Netakimab Usage And Synthesis

Uses

Netakimab is an anti-IL-17 monoclonal antibody. Nerelimomab can be used for research of ankylosing spondylitis, psoriatic arthritis, moderate-to-severe plaque psoriasis[1][2].

References

[1] Puig L, et al. Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial. Dermatol Ther (Heidelb). 2021 Aug;11(4):1319-1332. DOI:10.1007/s13555-021-00554-4
[2] Erdes S, et al. Primary efficacy of netakimab, a novel interleukin-17 inhibitor, in the treatment of active ankylosing spondylitis in adults. Clin Exp Rheumatol. 2020 Jan-Feb;38(1):27-34. Epub 2019 Apr 16. PMID:31025924

Netakimab(1796570-08-5)Related Product Information

• Trastuzumab
• Eldelumab
• Alemtuzumab
• Spesolimab
• Pritumumab
• Gatralimab
• Immunoglobulin G 1 (human-mouse monoclonal BIWA4 gamma1-chain antihuman antigen CD44v8), disulfide with human-mouse monoclonal BIWA4 gamma-chain, dimer
• Dalotuzumab
• Losatuxizumab
• Meterelin